Recruiting
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
J2X-MC-PYAH - ClinicalTrials.gov - NCT04634409
The purpose of this study is to measure how well LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes at least 1 visit to the study site, with the remainder of assessments performed in the home, local clinic, or by phone.
How long will I be in the trial?
Participation could last about 12 weeks and includes at least 1 visit to the study site, with the remainder of assessments performed in the home, local clinic, or by phone.
Recruiting
A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
J2X-MC-PYAH - ClinicalTrials.gov - NCT04634409
The purpose of this study is to measure how well LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in the body at various times during the study. Participation could last about 12 weeks and includes at least 1 visit to the study site, with the remainder of assessments performed in the home, local clinic, or by phone.
How long will I be in the trial?
Participation could last about 12 weeks and includes at least 1 visit to the study site, with the remainder of assessments performed in the home, local clinic, or by phone.
Key Requirements
Age :
18-64
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-64
Sex
All
Participants must
Participants must have mild to moderate COVID-19 illness: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, shortness of breath when active
Participants must test positive for COVID-19 within three days before starting the study
Participants must NOT
Participants must not be in the hospital
Participants must not be very overweight
Participants must not need a machine to help them breathe (ventilator)
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, Bamlanivimab, LY3832479, LY-CoV016, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
700
Trial Dates
October 2020 - March 2021
Trial Phase
2
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18-64
Sex
All
Participants must
Participants must have mild to moderate COVID-19 illness: Fever, cough, sore throat, not feeling well, headache, muscle pain, digestive symptoms, shortness of breath when active
Participants must test positive for COVID-19 within three days before starting the study
Participants must NOT
Participants must not be in the hospital
Participants must not be very overweight
Participants must not need a machine to help them breathe (ventilator)
Participants must not have a serious medical condition or infection other than COVID-19
Participants must not have received SARS-CoV-2 vaccine or plasma from a patient who has recovered from COVID-19 (convalescent plasma)
Participants must not be pregnant or breastfeeding
Trial Summary
Conditions the trial is for
COVID-19 (Coronavirus)
What the trial is testing?
LY3819253, Bamlanivimab, LY3832479, LY-CoV016, LY-CoV555
Could I receive a Placebo?
yes
Enrollment Goal
700
Trial Dates
October 2020 - March 2021
Trial Phase
2
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
COVID-19 (Coronavirus) Resources
COVID-19 Research
COVID-19 is caused by SARS-CoV-2, a novel coronavirus. Because it is a relatively new disease, scientists and physicians do not know much about it, and currently, there are not many medicines to treat it. That’s why we need clinical research—to test potential new treatments for COVID-19. Read on to see if a clinical trial may be right for you.
